Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas

Conditions:   Solid Tumors;   Lymphoma
Intervention:   Drug: ASTX660
Sponsor:   Astex Pharmaceuticals
Recruiting - verified March 2017

http://ift.tt/2ms1X7y